Mutations in the gene coding for the ligand TGF-β1 and causing the hyperactivation of the TGF-β signaling are responsible for the Camurati-Engelmann disease, characterized by increased bone density [125,126]. The gene discussed is TGFB1; the disease is Camurati-Engelmann disease.